The FDA prohibits the marketing of Juul products; pulse oximetry accuracy; COVID-19[feminine]

0
Source:

Healio Blanket
According to the results of a cohort study in JAMA internal medicine. Read more


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Healio editors have compiled the most read respiratory news published in May.

Highlights include the FDA issuing marketing denial orders to Juul Labs for all of their vaping devices and related products in the United States; the US news and world report‘s Best Children’s Hospitals for Respirology and Pulmonary Surgery; a study that identified eight asthma-COPD overlap signals; brensocatib did not improve the clinical status of COVID-19; and more.



Source: Adobe Stock.

Read these articles, and more, below, in no particular order.

FDA Denies Approval to Market Juul Vaping Products

In late June, the FDA issued marketing denial orders to Juul Labs for all of their vaping devices and related products. As a result, the company should stop selling and distributing these products, and those currently on the US market should be discontinued. SheaveD After

Texas Children’s Hospital Ranked #1 in the United States for Respirology and Pulmonary Surgery

Texas Children’s Hospital ranked #1 on US News and World Reports list of best children’s hospitals for pulmonology and lung surgery. Read more

Racial and ethnic bias in pulse oximetry accuracy may have delayed COVID-19 treatment for some

Continued use of CPAP may reduce mortality risk in people with obstructive sleep apnea

According to research published in Chest. Read more

Overuse of asthma reliever inhalers common, varies by practice

According to new data published in the British Journal of General Medicine. Read more

New lung cancer guidelines have reduced some screening disparities

New lung cancer screening guidelines from the U.S. Preventive Services Task Force, which lowered the age of inclusion and smoking intensity to qualify as high risk, led to an increase in the proportion of black people screened. Read more

California’s historic redlining linked to worst COVID-19 outcomes

SAN FRANCISCO — Residents affected by historic redlining in California communities had worse COVID-19 outcomes, according to new data presented at the American Thoracic Society’s international conference. Read more

Brensocatib did not improve the clinical status of patients with severe COVID-19

SAN FRANCISCO — Brensocatib, an investigational oral dipeptidyl peptidase 1 inhibitor, did not improve the clinical status of patients hospitalized with severe COVID-19 at 29 days, according to results from the STOP-COVID19 trial. Read more

Study sheds light on race/ethnicity differences in perception of healthcare delivery

SAN FRANCISCO — A new study highlights disparities in perceptions of health care satisfaction among black and Hispanic patients compared to white patients, according to data presented at the American Thoracic Society’s international conference. Read more

Study identifies eight asthma-COPD overlap signals

A new study has identified eight asthma-COPD overlapping signals that the researchers believe appear to represent loci that predispose patients to type 2 inflammation and therefore to serious long-term consequences of asthma, the researchers reported. in Chest. Read more

Share.

Comments are closed.